Rema Razdan

1.3k total citations
54 papers, 1.1k citations indexed

About

Rema Razdan is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Rema Razdan has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Orthopedics and Sports Medicine. Recurrent topics in Rema Razdan's work include Bone health and treatments (18 papers), Bone health and osteoporosis research (16 papers) and Bone Metabolism and Diseases (15 papers). Rema Razdan is often cited by papers focused on Bone health and treatments (18 papers), Bone health and osteoporosis research (16 papers) and Bone Metabolism and Diseases (15 papers). Rema Razdan collaborates with scholars based in India, United States and Israel. Rema Razdan's co-authors include Deepak Kumar Khajuria, D. Roy Mahapatra, Sumanta Goswami, David Karasik, Ramakrishna Vasireddi, M. R. Bhat, Mohammed Naseeruddin Inamdar, Indrani Datta, Bruce D. Hammock and Sarasija Suresh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Pharmacology and Experimental Therapeutics and Toxicology and Applied Pharmacology.

In The Last Decade

Rema Razdan

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rema Razdan India 19 313 252 249 185 123 54 1.1k
Takeshi Yamauchi Japan 23 461 1.5× 233 0.9× 202 0.8× 171 0.9× 77 0.6× 64 1.8k
Hamed Benghuzzi United States 17 326 1.0× 91 0.4× 103 0.4× 236 1.3× 67 0.5× 177 1.4k
Antonio Desmond McCarthy Argentina 25 1.0k 3.2× 442 1.8× 410 1.6× 137 0.7× 319 2.6× 47 1.9k
Yingqiang Shen China 20 661 2.1× 67 0.3× 152 0.6× 192 1.0× 36 0.3× 49 1.4k
Shihui Chen China 21 472 1.5× 85 0.3× 73 0.3× 264 1.4× 199 1.6× 56 1.8k
Viviana di Giacomo Italy 25 592 1.9× 80 0.3× 161 0.6× 94 0.5× 46 0.4× 78 1.6k
Sun Kim United States 17 240 0.8× 52 0.2× 94 0.4× 82 0.4× 77 0.6× 31 939
Chenglong Wang China 21 475 1.5× 125 0.5× 73 0.3× 200 1.1× 21 0.2× 94 1.2k
Yayu Wang Taiwan 26 842 2.7× 41 0.2× 197 0.8× 214 1.2× 86 0.7× 58 1.7k

Countries citing papers authored by Rema Razdan

Since Specialization
Citations

This map shows the geographic impact of Rema Razdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rema Razdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rema Razdan more than expected).

Fields of papers citing papers by Rema Razdan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rema Razdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rema Razdan. The network helps show where Rema Razdan may publish in the future.

Co-authorship network of co-authors of Rema Razdan

This figure shows the co-authorship network connecting the top 25 collaborators of Rema Razdan. A scholar is included among the top collaborators of Rema Razdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rema Razdan. Rema Razdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Datta, Indrani, et al.. (2019). Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model. Naunyn-Schmiedeberg s Archives of Pharmacology. 393(2). 147–165. 17 indexed citations
2.
Razdan, Rema, et al.. (2019). Potential of phloroglucinol to improve erectile dysfunction associated with streptozotocin-induced diabetes in rats. Journal of Integrative Medicine. 17(4). 282–287. 5 indexed citations
3.
4.
Razdan, Rema, et al.. (2018). An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats. Prostaglandins & Other Lipid Mediators. 136. 84–89. 22 indexed citations
5.
Datta, Indrani, et al.. (2017). Location and Number of Astrocytes Determine Dopaminergic Neuron Survival and Function Under 6-OHDA Stress Mediated Through Differential BDNF Release. Molecular Neurobiology. 55(7). 5505–5525. 27 indexed citations
6.
Razdan, Rema, et al.. (2017). Zolendronic Acid-Conjugated PLGA Ultrasmall Nanoparticle Loaded with Methotrexate as a Supercarrier for Bone-Targeted Drug Delivery. AAPS PharmSciTech. 18(6). 2227–2239. 10 indexed citations
7.
Datta, Indrani, et al.. (2017). Functional recovery upon human dental pulp stem cell transplantation in a diabetic neuropathy rat model. Cytotherapy. 19(10). 1208–1224. 35 indexed citations
8.
Razdan, Rema, et al.. (2017). Repositioning of molsidomine for its efficacy in diabetes induced erectile dysfunction in rats: In silico, in vitro and in vivo approach. Pharmacological Reports. 70(2). 309–315. 5 indexed citations
9.
Razdan, Rema, et al.. (2016). Preventive effect of phloroglucinol against adverse protein alterations in streptozotocin induced diabetic rats. International Journal of Herbal Medicine. 4(4). 103–107. 4 indexed citations
10.
Khajuria, Deepak Kumar, et al.. (2016). Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis. Materials Science and Engineering C. 63. 78–87. 52 indexed citations
11.
Razdan, Rema, et al.. (2016). Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats. Indian Journal of Pharmacology. 48(5). 544–544. 9 indexed citations
12.
Khajuria, Deepak Kumar, Rema Razdan, & D. Roy Mahapatra. (2014). Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model. European Journal of Pharmaceutical Sciences. 66. 173–183. 70 indexed citations
13.
Razdan, Rema, et al.. (2014). Efficacy of ellagic acid and sildenafil in diabetes-induced sexual dysfunction. Pharmacognosy Magazine. 10(39). 581–581. 46 indexed citations
14.
Khajuria, Deepak Kumar, et al.. (2014). Efeito combinado do ácido zoledrônico e do alfacalcidol no tratamento da osteoporose por desuso em ratos. Revista Brasileira de Reumatologia. 55(3). 240–250. 5 indexed citations
15.
Razdan, Rema, et al.. (2013). ANTI-INFLAMMATORY ACTIVITY OF SOME NEWLY SYNTHESIZED CHALCONES. International Journal of Pharmacy. 3(10). 728–733. 2 indexed citations
16.
Khajuria, Deepak Kumar, Rema Razdan, D. Roy Mahapatra, et al.. (2013). Improvement in Bone Properties by Using Risedronate Adsorbed Hydroxyapatite Novel Nanoparticle Based Formulation in a Rat Model of Osteoporosis. Journal of Biomedical Nanotechnology. 9(2). 193–201. 68 indexed citations
17.
Khajuria, Deepak Kumar, Rema Razdan, & D. Roy Mahapatra. (2011). Drugs for the management of osteoporosis: a review.. PubMed. 51(4). 365–82. 85 indexed citations
18.
Krishnamurthy, Praveen Thaggikuppe, et al.. (2008). Hepatoprotective activity of Scoparia dulcis linn. against carbon tetrachloride-induced liver cirrhosis in rats. 亚洲传统医药. 3(4). 153–159. 3 indexed citations
19.
Razdan, Rema, et al.. (2008). Preventive and curative effects of Vedic Guard against antitubercular drugs induced hepatic damage in rats. Pharmacognosy Magazine. 4(15). 182. 5 indexed citations
20.
Klykken, Paal C., et al.. (1977). Immunosuppressive effects of 8,9-epoxyhexahydrocannabinol (EHHC).. Journal of Pharmacology and Experimental Therapeutics. 201(3). 573–579. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Yamauchi Breakdown of academic impact, for papers by Hamed Benghuzzi Breakdown of academic impact, for papers by Antonio Desmond McCarthy Breakdown of academic impact, for papers by Yingqiang Shen Breakdown of academic impact, for papers by Shihui Chen Breakdown of academic impact, for papers by Viviana di Giacomo Breakdown of academic impact, for papers by Sun Kim Breakdown of academic impact, for papers by Chenglong Wang Breakdown of academic impact, for papers by Yayu Wang
Rankless by CCL
2026